|
|
Volumn 24, Issue 6, 2014, Pages 1941-1950
|
|
Controlled release bevacizumab in thermoresponsive hydrogel found to inhibit angiogenesis
a,b
c
d
c
|
|
Author keywords
Angiogenesis; Bevacizumab; Drug delivery system; Thermo responsive hydrogel
|
|
Indexed keywords
BIOCOMPATIBILITY;
BIODEGRADATION;
BLOCK COPOLYMERS;
CELLS;
CYTOTOXICITY;
DRUG DELIVERY;
MOTION PICTURE EXPERTS GROUP STANDARDS;
OPHTHALMOLOGY;
POLYETHYLENE GLYCOLS;
RING OPENING POLYMERIZATION;
SOL-GEL PROCESS;
SOL-GELS;
AGE-RELATED MACULAR DEGENERATION;
ANGIOGENESIS;
BEVACIZUMAB;
CONTROLLED RELEASE;
DRUG DELIVERY SYSTEM;
INTRAVITREAL INJECTION;
POLY LACTIC-CO-GLYCOLIC ACID;
THERMO-RESPONSIVE HYDROGELS;
HYDROGELS;
BEVACIZUMAB;
COPOLYMER;
EOSIN;
HEMATOXYLIN;
POLYGLACTIN;
ANGIOGENESIS INHIBITOR;
DELAYED RELEASE FORMULATION;
HYDROGEL;
MONOCLONAL ANTIBODY;
ANGIOGENESIS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ANTIANGIOGENIC ACTIVITY;
AQUEOUS SOLUTION;
BODY TEMPERATURE;
CELL GROWTH;
CELL PROLIFERATION;
CONFERENCE PAPER;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
HYDROGEL;
HYDROPHILICITY;
HYDROPHOBICITY;
IN VIVO STUDY;
NONHUMAN;
PHASE TRANSITION;
POLYMERIZATION;
RABBIT;
STAINING;
SYNTHESIS;
TRANSITION TEMPERATURE;
ABSORPTION;
ADMINISTRATION AND DOSAGE;
ANIMAL;
CHEMISTRY;
CHOROIDAL NEOVASCULARIZATION;
DELAYED RELEASE FORMULATION;
DIFFUSION;
HEAT;
NEOVASCULARIZATION, PATHOLOGIC;
PATHOLOGY;
TEMPERATURE;
TREATMENT OUTCOME;
ABSORPTION, PHYSICOCHEMICAL;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHOROIDAL NEOVASCULARIZATION;
DELAYED-ACTION PREPARATIONS;
DIFFUSION;
HOT TEMPERATURE;
HUMANS;
HYDROGELS;
NEOVASCULARIZATION, PATHOLOGIC;
RABBITS;
TEMPERATURE;
TREATMENT OUTCOME;
|
|
EID: 84907261533
PISSN: 09592989
EISSN: 18783619
Source Type: Journal
DOI: 10.3233/BME-141003 Document Type: Conference Paper |
|
Times cited : (37)
|
|
References (9)
|
